Article
Circulating erythropoietin concentration associates with thromboembolism in sickle cell disease.
British journal of haematology - 1 Jul 2026
Zhang Xu, Shah Binal N, Han Jin, Nouraie Mehdi, Zhang Yingze, Machado Roberto F, Gladwin Mark T, Saraf Santosh L, Gordeuk Victor R
Abstract excerpt
Elevated erythropoietin (EPO) concentration associates with thrombotic risk in hypoxic conditions, hereditary erythrocytosis and treatment of anaemia with recombinant EPO. We evaluated sickle cell disease (SCD) patients from the University of Illinois at Chicago (UIC) and the Treatment of Pulmonary Hypertension and SCD with Sildenafil Therapy (Walk-PHaSST) study and found that higher serum EPO concentration...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
